136 related articles for article (PubMed ID: 37268474)
1. Serial electrocardiogram recordings revealed a high prevalence of QT interval prolongation in patients with tuberculosis receiving fluoroquinolones.
Ju KS; Lee RG; Lin HC; Chen JH; Hsu BF; Wang JY; Van Dong N; Yu MC; Lee CH
J Formos Med Assoc; 2023 Dec; 122(12):1255-1264. PubMed ID: 37268474
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
[TBL] [Abstract][Full Text] [Related]
3. Effects of Bedaquiline Combined with Fluoroquinolone and/or Clofazimine on QT Interval in Patients with Multidrug-Resistant Tuberculosis: a Retrospective Study.
Li R; Ma JB; Yang H; Yang H; Yang XJ; Wu YQ; Ren F
Microbiol Spectr; 2023 Aug; 11(4):e0104823. PubMed ID: 37310268
[TBL] [Abstract][Full Text] [Related]
4. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced QT prolongation when QT interval is measured in each of the 12 ECG leads in men and women in a thorough QT study.
Panicker GK; Salvi V; Karnad DR; Chakraborty S; Manohar D; Lokhandwala Y; Kothari S
J Electrocardiol; 2014; 47(2):155-7. PubMed ID: 24388488
[TBL] [Abstract][Full Text] [Related]
6. Managing malaria in tuberculosis patients on fluoroquinolone-containing regimens: assessing the risk of QT prolongation.
Murphy ME; Singh KP; Laurenzi M; Brown M; Gillespie SH
Int J Tuberc Lung Dis; 2012 Feb; 16(2):144-9, i-iii. PubMed ID: 22236913
[TBL] [Abstract][Full Text] [Related]
7. Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis.
Putnikovic M; Jordan Z; Munn Z; Borg C; Ward M
Drug Saf; 2022 Oct; 45(10):1037-1048. PubMed ID: 35947343
[TBL] [Abstract][Full Text] [Related]
8. Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks.
Tagawa M; Ochiai S; Nakamura Y; Sato A; Chinushi M
Heart Vessels; 2016 Jul; 31(7):1200-5. PubMed ID: 26022375
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Ott CA; Walroth TA; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Jun; 41(6):494-500. PubMed ID: 33772822
[TBL] [Abstract][Full Text] [Related]
10. Ciprofloxacin does not Prolong the QTc Interval: A Clinical Study in ICU Patients and Review of the Literature.
Heemskerk C; Woldman E; Pereboom M; Van der Hoeven R; Mantel-Teeuwisse A; Van Gemeren C; Becker ML
J Pharm Pharm Sci; 2017; 20(1):360-364. PubMed ID: 29145929
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study.
Ali Z; Ismail M; Nazar Z; Khan F; Khan Q; Noor S
BMC Psychiatry; 2020 Jun; 20(1):277. PubMed ID: 32493330
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of QT prolongation in a population of patients with substance use disorders.
Scott AJ; Dunlop AJ; Brown A; Sadler C; Isbister GK
Drug Alcohol Rev; 2017 Mar; 36(2):239-244. PubMed ID: 27241860
[TBL] [Abstract][Full Text] [Related]
13. QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
Briasoulis A; Agarwal V; Pierce WJ
Cardiology; 2011; 120(2):103-10. PubMed ID: 22156660
[TBL] [Abstract][Full Text] [Related]
14. Meperidine-induced QTc-interval prolongation: prevalence, risk factors, and correlation to plasma drug and metabolite concentrations
.
Keller GA; Villa Etchegoyen MC; Fernández N; Olivera NM; Quiroga PN; Diez RA; Di Girolamo G
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):275-285. PubMed ID: 27509828
[TBL] [Abstract][Full Text] [Related]
15. Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data.
Choi BJ; Koo Y; Kim TY; Lim HS; Yoon D
PLoS One; 2022; 17(1):e0263117. PubMed ID: 35100302
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study.
Pickham D; Helfenbein E; Shinn JA; Chan G; Funk M; Weinacker A; Liu JN; Drew BJ
Crit Care Med; 2012 Feb; 40(2):394-9. PubMed ID: 22001585
[TBL] [Abstract][Full Text] [Related]
17. Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach.
Panicker GK; Karnad DR; Kadam P; Badilini F; Damle A; Kothari S
Br J Pharmacol; 2016 Apr; 173(8):1373-80. PubMed ID: 26784016
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.
Tisdale JE; Jaynes HA; Kingery JR; Mourad NA; Trujillo TN; Overholser BR; Kovacs RJ
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):479-87. PubMed ID: 23716032
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of ECG leads used to assess QT prolongation.
Sadanaga T; Sadanaga F; Yao H; Fujishima M
Cardiology; 2006; 105(3):149-54. PubMed ID: 16449814
[TBL] [Abstract][Full Text] [Related]
20. Incidence and outcomes of long QTc in acute medical admissions.
Mahmud R; Gray A; Nabeebaccus A; Whyte MB
Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
